The Pathophysiology and Pharmacological Treatment of Huntington Disease

The Pathophysiology and Pharmacological Treatment of Huntington Disease

Saved in:

Bibliographic Details
Main Authors:	Connie Pidgeon, Hugh Rickards
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Behavioural Neurology
Online Access:	http://dx.doi.org/10.3233/BEN-2012-120267
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring the role of ferroptosis pathways in Huntington's disease: Insight of pathophysiology to emerging treatment
by: Mohd Haris Jamal, et al.
Published: (2025-06-01)

Prospects of etiopathogenetic treatment of Huntington’s disease
by: O. B. Kondakova, et al.
Published: (2023-03-01)

deutetrabenazine for the treatment of chorea associated with Huntington’s disease
by: Harshit Gupta, et al.
Published: (2022-06-01)

The Pathophysiology of Vasovagal Syncope and New Approaches to its Pharmacological Treatment
by: Dalyia Abu-Ghazaleh MD, et al.
Published: (2025-06-01)

Américo Negrette and Huntington's disease
by: Mariana Moscovich, et al.
Published: (2011-08-01)

Language impairment in Huntington's disease
by: Mariana Jardim Azambuja, et al.
Published: (2012-06-01)

Oxidative Stress in Huntington’s Disease
by: Félix Javier Jiménez-Jiménez, et al.
Published: (2025-04-01)

Huntington's Disease: An Immune Perspective
by: Annapurna Nayak, et al.
Published: (2011-01-01)

Juvenile Huntington disease in Argentina
by: Emilia Mabel Gatto, et al.
Published: (2015-01-01)

Tractography of the corpus callosum in Huntington's disease.
by: Owen Phillips, et al.
Published: (2013-01-01)

The Ubiquitin-Proteasome Pathway in Huntington's Disease
by: Siddhartha Mitra, et al.
Published: (2008-01-01)

Gene Silencing Therapies for Huntington’s Disease
by: Chunlan Hao, et al.
Published: (2025-05-01)

Clinical presentation of juvenile Huntington disease
by: Ruocco Heloísa H., et al.
Published: (2006-01-01)

Altered interhemispheric connectivity in Huntington’s Disease
by: Ali Demir, et al.
Published: (2024-01-01)

RNA splicing modulator for Huntington’s disease treatment induces peripheral neuropathy
by: Florian Krach, et al.
Published: (2025-05-01)

Role of Adenosine A2A Receptors in Modulating Synaptic Functions and Brain Levels of BDNF: a Possible Key Mechanism in the Pathophysiology of Huntington's Disease
by: Maria Teresa Tebano, et al.
Published: (2010-01-01)

Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications
by: Ni Yangyue, et al.
Published: (2024-09-01)

Ventricular ion channels and arrhythmias: an overview of physiology, pathophysiology and pharmacology
by: Liu Shiqi, et al.
Published: (2025-03-01)

Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
by: Samuel Frank, et al.
Published: (2024-09-01)

The Role of the Caudate in Nonmotor Behaviors in Huntington’s Disease
by: D. H. Jacobs, et al.
Published: (1992-01-01)

Molecular diagnosis of Huntington disease in Brazilian patients
by: TEREZA C. LIMA E SILVA, et al.
Published: (2000-03-01)

Huntington's disease: clinical aspects in 81 patients
by: Monica Santoro Haddad
Published: (1996-06-01)

Huntington's disease presenting as posterior cortical atrophy
by: L Caixeta
Published: (2011-01-01)

Transcriptome Study in Sicilian Patients with Huntington’s Disease
by: Michele Salemi, et al.
Published: (2025-02-01)

Huntington disease: DNA analysis in brazilian population
by: RASKIN SALMO, et al.
Published: (2000-01-01)

Retinal and choroidal morphological changes in Huntington's disease
by: S. N. Svetozarskiy, et al.
Published: (2019-03-01)

Insulin-like growth factor 2 reduces Huntington’s disease aggregates via AKT and NF-κB signaling in huntington’s disease
by: Yun-Shiuan Tung, et al.
Published: (2025-07-01)

Emotional speech markers of psychiatric disturbance in Huntington’s disease
by: Lucie Chenain, et al.
Published: (2025-08-01)

Lessons Learned from the Transgenic Huntington's Disease Rats
by: Rinske Vlamings, et al.
Published: (2012-01-01)

Theory of mind impairment in Huntington's disease patients and their relatives
by: Leo Bayliss, et al.

Careful clinical observation is essential for diagnosis of Huntington's disease
by: Ken Nakamura, et al.
Published: (2012-08-01)

The association between lifestyle factors and mortality in Huntington's disease
by: E. Cubo, et al.
Published: (2025-05-01)

Huntington’s disease modeling on HEK293 cell line
by: D. V. Sharipova, et al.
Published: (2017-12-01)

Differential response of neurons to autophagy modulation in Huntington’s disease
by: Ankit Sharma, et al.
Published: (2025-12-01)

Huntington’s Disease in a Patient Misdiagnosed as Conversion Disorder
by: João Machado Nogueira, et al.
Published: (2018-01-01)

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives
by: Ching-Pang Chang, et al.
Published: (2024-10-01)

Drug-Induced Myocardial Infarction: A Review of Pharmacological Triggers and Pathophysiological Mechanisms
by: Ioana Boarescu, et al.
Published: (2024-12-01)

Psychotic Manifestations in Huntington’s Disease: A Systematic Review of Clinical Presentation, Treatment Approaches, and Outcomes
by: Aliu Yakubu, et al.
Published: (2025-06-01)

Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
by: Melanie Alpaugh, et al.
Published: (2017-10-01)

Juvenile Huntington's disease confirmed by genetic examination in twins Doença de Huntington juvenil confirmada por exame genético em gêmeas
by: GILBERTO LEVY, et al.
Published: (1999-09-01)